To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients

NCT02542605 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Erenumab
DRUG: Placebo
DRUG: PACAP-38 Challenge Agent

Sponsor

Amgen